13 Recruiting Metastatic Malignant Solid Neoplasm Phase 1 Clinical Trials
Active phase 1 studies for metastatic malignant solid neoplasm enrolling across the USA. Verify eligibility and contact site coordinators.
All Metastatic Malignant Solid Neoplasm studiesPhase 1 Studies for Metastatic Malignant Solid Neoplasm
Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
View Study & Checklist ➔Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers
📍 Mayo Clinic in Florida — Jacksonville, Florida
View Study & Checklist ➔